EDSA NASDAQ
Edesa Biotech, Inc.
1W: -3.7%
1M: -18.9%
3M: -46.5%
YTD: +157.3%
1Y: +50.2%
3Y: -30.2%
5Y: -93.2%
$3.86
-0.15 (-3.74%)
Weekly Expected Move ±12.9%
$3
$3
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-11-22
Earliest Filing
2024-10-31
Latest Filing
partner: 3
investor: 1
Counterparties (Filed by EDSA)
4 relationshipsCompanies named in EDSA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. | EDSA | partner | Company issuing units in a securities purchase agreement | 2024-10-31 | View |
| Pardeep Nijhawan Medicine Professional Corporation | — | investor | Purchaser acquiring units in a securities purchase agreement | 2024-10-31 | View |
| Canaccord Genuity LLC | — | partner | Sales agent and principal for the equity distribution agreement | 2023-03-27 | View |
| RBC Capital Markets, LLC | — | partner | Equity Distribution Agreement sales agent and principal for common share offerings | 2021-11-22 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-20 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-11 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-06-05 | Other Events | View | |
| 2026-05-29 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-15 | Officer/Director Change | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-02-24 | Other Events | View | |
| 2026-02-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-28 | Other Events | View | |
| 2025-09-30 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation | Agreement | View |
| 2025-09-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-28 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-04 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-02-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR